JP2006500315A5 - - Google Patents

Download PDF

Info

Publication number
JP2006500315A5
JP2006500315A5 JP2003559504A JP2003559504A JP2006500315A5 JP 2006500315 A5 JP2006500315 A5 JP 2006500315A5 JP 2003559504 A JP2003559504 A JP 2003559504A JP 2003559504 A JP2003559504 A JP 2003559504A JP 2006500315 A5 JP2006500315 A5 JP 2006500315A5
Authority
JP
Japan
Prior art keywords
alkyl
group
hydrogen
heterocyclic
alkylcarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003559504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006500315A (ja
Filing date
Publication date
Priority claimed from US10/043,848 external-priority patent/US20030134835A1/en
Application filed filed Critical
Priority claimed from PCT/US2003/000733 external-priority patent/WO2003059342A1/en
Publication of JP2006500315A publication Critical patent/JP2006500315A/ja
Publication of JP2006500315A5 publication Critical patent/JP2006500315A5/ja
Pending legal-status Critical Current

Links

JP2003559504A 2002-01-11 2003-01-10 糖尿病状態に用いるヒスタミン−3受容体リガンド Pending JP2006500315A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/043,848 US20030134835A1 (en) 2002-01-11 2002-01-11 Histamine-3 receptor ligands for diabetes conditions
US10/326,546 US20030153548A1 (en) 2002-01-11 2002-12-23 Histamine-3 receptor ligands for diabetic conditions
PCT/US2003/000733 WO2003059342A1 (en) 2002-01-11 2003-01-10 Histamine-3 receptor ligands for diabetic conditions

Publications (2)

Publication Number Publication Date
JP2006500315A JP2006500315A (ja) 2006-01-05
JP2006500315A5 true JP2006500315A5 (https=) 2006-02-16

Family

ID=26720877

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003559504A Pending JP2006500315A (ja) 2002-01-11 2003-01-10 糖尿病状態に用いるヒスタミン−3受容体リガンド

Country Status (8)

Country Link
US (1) US20050113435A1 (https=)
EP (1) EP1474132A1 (https=)
JP (1) JP2006500315A (https=)
AU (1) AU2003235687A1 (https=)
CA (1) CA2473232C (https=)
MX (1) MXPA04006777A (https=)
PL (1) PL373586A1 (https=)
WO (1) WO2003059342A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620839B2 (en) * 2000-07-13 2003-09-16 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
US6822101B2 (en) 2002-09-16 2004-11-23 Abbott Laboratories Process for preparing amine-substituted benzofurans
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
WO2005009471A1 (en) * 2003-07-28 2005-02-03 Osaka Industrial Promotion Organization Composition for lowering blood-sugar level
US7435837B2 (en) 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
EP1717233A1 (en) * 2005-04-29 2006-11-02 Bioprojet Histamine H3-receptor ligands and their therapeutic application
EP1717234A1 (en) * 2005-04-29 2006-11-02 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
EP1717235A3 (en) * 2005-04-29 2007-02-28 Bioprojet Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
FR2903904A1 (fr) * 2006-07-21 2008-01-25 Bioprojet Soc Civ Ile Association de modafinil et d'un antagoniste ou agoniste inverse du recepteur h3
JP2010520199A (ja) * 2007-03-02 2010-06-10 シェーリング コーポレイション ピペリジン誘導体およびその使用方法
WO2008108958A2 (en) * 2007-03-02 2008-09-12 Schering Corporation Benzimidazole derivatives and methods of use thereof
WO2022113008A1 (en) 2020-11-27 2022-06-02 Richter Gedeon Nyrt. Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096331A (en) * 1976-12-28 1978-06-20 A. H. Robins Company, Incorporated 1-Substituted-3-aminoethoxypyrrolidines
GB2056441B (en) * 1979-07-26 1983-07-06 Kyowa Hakko Kogyo Kk Derivatives of benzo(b)furan and pharmaceutical compositions containing them
US4452986A (en) * 1982-06-08 1984-06-05 The Upjohn Company Imidazolyl-substituted benzofurans
US4447620A (en) * 1982-06-08 1984-05-08 The Upjohn Company Imidazolyl-substituted benzothiophenes
NZ270418A (en) * 1994-02-07 1997-09-22 Eisai Co Ltd Polycyclic triazole & imidazole derivatives, antifungal compositions
EP0977753A1 (en) * 1997-12-02 2000-02-09 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
US6136559A (en) * 1998-10-07 2000-10-24 Ortho Pharmaceutical Corporation DNA encoding as human histamine receptor of the H3 subtype
AU3957600A (en) * 1999-04-26 2000-11-10 Boehringer Ingelheim International Gmbh Piperidyl-imidazole derivatives, their preparations and therapeutic uses
US6437147B1 (en) * 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
AU2001244087A1 (en) * 2000-03-17 2001-09-24 Boehringer Ingelheim International G.M.B.H Condensed imidazoles as histamine h3 receptor ligands
US6620839B2 (en) * 2000-07-13 2003-09-16 Abbott Laboratories 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
US6316475B1 (en) * 2000-11-17 2001-11-13 Abbott Laboratories Aminoalkoxybiphenylcarboxamides as histamine-3 receptor ligands and their therapeutic applications
CN101444496B (zh) * 2001-06-12 2011-04-13 维尔斯达医疗公司 用于治疗代谢失调的化合物
CN1642599A (zh) * 2002-02-27 2005-07-20 辉瑞产品公司 Acc抑制剂

Similar Documents

Publication Publication Date Title
JP2006500315A5 (https=)
JP2010527373A5 (https=)
JP2014524934A5 (https=)
CA2565813A1 (en) Substituted methyl aryl or heteroaryl amide compounds
JP2011057693A5 (https=)
JP2011529029A5 (https=)
JP2013500267A5 (https=)
GEP20094723B (en) Tetraazabenzo [e] azulene derivatives and analogs thereof
CA2613303A1 (en) An oxime derivative for use as a glucokinase activator
RU2006116887A (ru) Производные n-[гетероарил(пиперидин-2-ил)метил]бензамида, способ получения указанных соединений и их применение в терапии
JP2008513498A5 (https=)
JP2004520292A5 (https=)
RU2006101452A (ru) Пиридазинил-пиперазины и их применение в качестве лигандов h3 гистаминового рецептора
JP2014511869A5 (https=)
JP2011507896A5 (https=)
JP2010510233A5 (https=)
JP2009526831A5 (https=)
CA2409741A1 (en) Tnf-.alpha. production inhibitors
JP2006515339A5 (https=)
JP2006506443A5 (https=)
JP2009511519A5 (https=)
RU2009123525A (ru) ПРОИЗВОДНЫЕ 5-СУЛЬФАНИЛМЕТИЛ[1,2,4}ТРИАЗОЛ[1,5-а]ПИРИМИДИН-7-ОЛА В КАЧЕСТВЕ АНТАГОНИСТОВ CXCR2
JP2006501201A5 (https=)
JP2007520440A5 (https=)
CA2617817A1 (en) Thiazole derivatives for treating or preventing sleep disorders